DARE
Price
$2.42
Change
+$0.02 (+0.83%)
Updated
Aug 1 closing price
Capitalization
21.29M
NVCT
Price
$6.80
Change
-$0.16 (-2.30%)
Updated
Aug 1 closing price
Capitalization
142.08M
4 days until earnings call
Interact to see
Advertisement

DARE vs NVCT

Header iconDARE vs NVCT Comparison
Open Charts DARE vs NVCTBanner chart's image
Dare Bioscience
Price$2.42
Change+$0.02 (+0.83%)
Volume$112.94K
Capitalization21.29M
Nuvectis Pharma
Price$6.80
Change-$0.16 (-2.30%)
Volume$99.43K
Capitalization142.08M
DARE vs NVCT Comparison Chart in %
Loading...
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DARE vs. NVCT commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DARE is a Hold and NVCT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (DARE: $2.42 vs. NVCT: $6.80)
Brand notoriety: DARE and NVCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DARE: 6% vs. NVCT: 55%
Market capitalization -- DARE: $21.29M vs. NVCT: $142.08M
DARE [@Biotechnology] is valued at $21.29M. NVCT’s [@Biotechnology] market capitalization is $142.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DARE’s FA Score shows that 0 FA rating(s) are green whileNVCT’s FA Score has 0 green FA rating(s).

  • DARE’s FA Score: 0 green, 5 red.
  • NVCT’s FA Score: 0 green, 5 red.
According to our system of comparison, NVCT is a better buy in the long-term than DARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DARE’s TA Score shows that 2 TA indicator(s) are bullish while NVCT’s TA Score has 4 bullish TA indicator(s).

  • DARE’s TA Score: 2 bullish, 7 bearish.
  • NVCT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NVCT is a better buy in the short-term than DARE.

Price Growth

DARE (@Biotechnology) experienced а -6.56% price change this week, while NVCT (@Biotechnology) price change was -12.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.14%. For the same industry, the average monthly price growth was +15.55%, and the average quarterly price growth was +36.18%.

Reported Earning Dates

DARE is expected to report earnings on May 13, 2025.

NVCT is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+0.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVCT($142M) has a higher market cap than DARE($21.3M). NVCT YTD gains are higher at: 25.693 vs. DARE (-22.436). NVCT (-21.02M) and DARE (-21.82M) have comparable annual earnings (EBITDA) . NVCT has more cash in the bank: 29.9M vs. DARE (10.3M). DARE has higher revenues than NVCT: DARE (25.9K) vs NVCT (0).
DARENVCTDARE / NVCT
Capitalization21.3M142M15%
EBITDA-21.82M-21.02M104%
Gain YTD-22.43625.693-87%
P/E Ratio0.10N/A-
Revenue25.9K0-
Total Cash10.3M29.9M34%
Total Debt3.57MN/A-
FUNDAMENTALS RATINGS
DARE: Fundamental Ratings
DARE
OUTLOOK RATING
1..100
93
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
78
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DARENVCT
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 12 days ago
88%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN9.660.23
+2.44%
Haleon plc
BPRN29.95-0.24
-0.79%
Princeton Bancorp
MLYS13.66-0.48
-3.43%
Mineralys Therapeutics
RELY15.79-0.71
-4.30%
Remitly Global
MYNZ1.33-0.38
-22.22%
Mainz Biomed N.V.

DARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, DARE has been closely correlated with AZTR. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if DARE jumps, then AZTR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DARE
1D Price
Change %
DARE100%
+0.83%
AZTR - DARE
73%
Closely correlated
-2.92%
CYTK - DARE
42%
Loosely correlated
-2.52%
AXON - DARE
39%
Loosely correlated
-1.72%
AMRN - DARE
34%
Loosely correlated
+4.41%
SNTI - DARE
32%
Poorly correlated
-1.18%
More

NVCT and

Correlation & Price change

A.I.dvisor tells us that NVCT and PDSB have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVCT and PDSB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCT
1D Price
Change %
NVCT100%
-2.30%
PDSB - NVCT
31%
Poorly correlated
+1.87%
DARE - NVCT
30%
Poorly correlated
+0.83%
SGMT - NVCT
27%
Poorly correlated
-5.06%
AGIO - NVCT
26%
Poorly correlated
-5.96%
THRD - NVCT
26%
Poorly correlated
N/A
More